Immunome Inc. (IMNM): Price and Financial Metrics
IMNM Price/Volume Stats
| Current price | $9.33 | 52-week high | $30.96 |
| Prev. close | $9.39 | 52-week low | $6.93 |
| Day low | $8.97 | Volume | 700,300 |
| Day high | $9.36 | Avg. volume | 772,027 |
| 50-day MA | $12.81 | Dividend yield | N/A |
| 200-day MA | $16.05 | Market Cap | 582.35M |
IMNM Stock Price Chart Interactive Chart >
Immunome Inc. (IMNM) Company Bio
Immunome, Inc. operates as a transformative immuno-oncology company. It creates new, safe, and powerful cancer therapies by targeting stem cell and universal cancer antigens. The firm offers discovery engine that enables the simultaneous discovery of novel tumor antigens and the cognate native human antibodies that target those antigens. The company was founded by Scott K. Dessain and Gregory P. Licholai on March 2, 2006 and is headquartered in Exton, PA.
IMNM Price Returns
| 1-mo | -20.32% |
| 3-mo | -39.61% |
| 6-mo | -34.39% |
| 1-year | 17.51% |
| 3-year | -37.34% |
| 5-year | N/A |
| YTD | -12.80% |
| 2023 | 384.16% |
| 2022 | -82.95% |
| 2021 | 33.88% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...